Rapid Micro Biosystems Reports Preliminary FY23 Revenue Of $22.4M-$22.6M, Up 30% Y/Y Versus Consensus Of $22.41M
Portfolio Pulse from Benzinga Newsdesk
Rapid Micro Biosystems announced preliminary FY23 revenue between $22.4M-$22.6M, reflecting a 30% increase year-over-year and aligning with the consensus estimate of $22.41M.
January 10, 2024 | 12:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rapid Micro Biosystems reported a 30% year-over-year increase in preliminary FY23 revenue, meeting consensus estimates.
Meeting or exceeding consensus revenue estimates generally has a positive impact on investor sentiment and can lead to a short-term increase in stock price. The reported 30% Y/Y growth indicates strong performance, which is likely to be viewed favorably by the market.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100